dichlororibofuranosylbenzimidazole has been researched along with Cancer of Mouth in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, oral squamous carcinoma cells (SCC2/88) had a two-fold increase in PTHrP mRNA stability (from 45 to 90 min) in response to treatment with TGFbeta1." | 1.31 | Messenger RNA stability of parathyroid hormone-related protein regulated by transforming growth factor-beta1. ( Capen, CC; Rosol, TJ; Sellers, RS, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sellers, RS | 1 |
| Capen, CC | 1 |
| Rosol, TJ | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Cancer of Mouth
| Article | Year |
|---|---|
Messenger RNA stability of parathyroid hormone-related protein regulated by transforming growth factor-beta1.
Topics: 3' Untranslated Regions; Animals; Carcinoma, Squamous Cell; Cell-Free System; Cross-Linking Reagents | 2002 |